Skip to main content

Advertisement

ADVERTISEMENT

News

Dermacyte - Merakris Therapeutics 

https://clinicaltrials.gov/study/NCT06444906

An 85-patient 2-part RCT will examine the efficacy of Dermacyte amniotic wound care matrix for the treatment of DFUs vs SoC with primary outcome of wound closure at 12 weeks. Not yet recruiting; the estimated study completion is May 2025. clinicaltrials.gov

Advertisement

Advertisement

Advertisement